Pleno
Latest round
- Series B
Last raised
- Dec 2024
Total raised
- $64M
Investors
- 4
About Pleno
Based in California, US, and founded in 2017 by Pieter van Rooyen (CEO), Pleno Inc is a biotechnology research company that provides biological target detection and diagnostic solutions for clinical testing and biomedical research. In December 2024, Pleno Inc. The company employs its proprietary Hypercoding technology that uses telecommunications signal-processing techniques to deliver targeted biological information on DNA, RNA, methylation, and proteomic content, enabling a wide range of applications ranging from screening and detection to diagnostics, prognostics, and other diagnostic and therapeutic purposes.
Who invested in Pleno
4 investors across 3 rounds
See all investors in Pleno
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pleno
Who invested in Pleno?
Pleno has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pleno raised?
Pleno has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Pleno last raise money?
Pleno's most recent round on record is a Series B, in Dec 2024.
What does Pleno do?
Based in California, US, and founded in 2017 by Pieter van Rooyen (CEO), Pleno Inc is a biotechnology research company that provides biological target detection and diagnostic solutions for clinical testing and biomedical research.
Where is Pleno headquartered?
Pleno is headquartered in San Diego, US.
Which VCs invest in companies like Pleno?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Pleno's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Pleno? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.